PhRMA Advises Members To Respect Independence Of Patient Organizations
This article was originally published in The Pink Sheet Daily
Association’s principles on interactions with patient organizations says no company should require that it be the sole funder of a group.
You may also be interested in...
FDA is ready to bring patient voices and perspectives into the drug approval framework. Practically, that means that drug sponsors will have to develop new skills and structures for working with a familiar stakeholder group at an unfamiliar point in the drug development process. The new challenge was a major theme at PhRMA’s 2012 Annual Meeting.
Amgen exec calls for more informal agency feedback and alignment between review divisions in understanding design methodologies.